Inflammatory Bowel Disease Specimens
Inflammatory bowel disease (IBD) is a group of long-term conditions that cause inflammation in the digestive tract. According to the CDC’s National Center for Health Statistics, about 1.6% of U.S. adults had ever been diagnosed with IBD in 2023–2024.
Even so, the exact cause is still unknown, and not every patient responds to current treatments. Researchers therefore need well-characterized Inflammatory Bowel Disease Specimens to find better biomarkers, predict treatment response, and test new therapies.
At Bay Biosciences, we understand this need and provide high-quality human biospecimens that support gut and immune research. These include Crohn’s Disease Samples, Ulcerative Colitis Samples, IBD Plasma Samples and other Gastrointestinal Disease Samples.
Understanding Inflammatory Bowel Disease
IBD has two main forms: Crohn’s disease and ulcerative colitis.
Crohn’s disease typically affects the last part of the small intestine which is called the ileum, and parts of the colon. However, it can involve other areas. The inflammation may reach the deeper layers of the bowel wall.
On the other hand, Ulcerative colitis affects the colon and rectum, where it causes inflammation and ulcers in the innermost lining.
Both conditions follow an unpredictable course, with periods of active disease followed by remission.
For this reason, researchers rely on disease-specific Colon Tissue Samples and matched biofluids to link what happens in the gut to patient outcomes.
It is important to highlight that IBD differs from irritable bowel syndrome (IBS), a functional gut disorder, and also from celiac disease.
Symptoms of Inflammatory Bowel Disease
Symptoms depend on where the inflammation is and how severe it is. They often appear in flares, followed by quieter periods.
Common signs include:
- Diarrhea
- Abdominal pain and cramping
- Loss of appetite
- Unexplained weight loss
- Fatigue
- Fever in some patients
These signs can also appear in other conditions, including bacterial gastroenteritis. Doctors need further testing to confirm IBD.
Over time, IBD can lead to complications such as dehydration, malnutrition, and primary sclerosing cholangitis, a rare liver disease.
Causes and Risk Factors of Inflammatory Bowel Disease
The exact cause of IBD is not known. Diet and stress do not cause it, although they can make symptoms worse in some people. Instead, researchers think several factors act together.
Firstly, genetic susceptibility matters. Variants in the NOD2 gene are linked to Crohn’s disease and affect how gut cells recognize and clear bacteria.
Secondly, the immune system reacts abnormally to gut bacteria in genetically susceptible people. This leads to ongoing inflammation, and researchers also study the role of autoimmune mechanisms.
Thirdly, the gut microbiome and the intestinal barrier play a role. Environmental factors can change the microbiome, which may weaken the barrier and trigger inappropriate immune activation.
Scientists are still working out how all these pieces fit together!
Several risk factors are also known. These include:
- Age: many people are diagnosed before age 30, but some are diagnosed in their 50s or 60s
- Family history: a parent, sibling, or child with IBD raises the risk
- Race and ethnicity: IBD is more common in white people, but cases are rising in other groups
- Smoking: the most important controllable risk factor for Crohn’s disease
- Nonsteroidal anti-inflammatory drugs (NSAIDs): these may raise the risk of Crohn’s disease or worsen it
Note: Having a risk factor does not mean a person will get the disease, and some patients have none of them.
Diagnosis of Inflammatory Bowel Disease
Diagnosis usually begins with a conversation. The doctor takes a detailed history of your symptoms, then does a physical exam, which may include checking the abdomen for pain or tenderness.
No single test confirms IBD, so doctors also have to rule out other causes of similar symptoms, such as infection, irritable bowel syndrome, diverticulitis, and colon cancer.
Blood tests can’t confirm IBD on their own, but they help exclude look-alike conditions.
Similarly, Stool tests check for infection and measure inflammation.
A colonoscopy is almost always recommended, and biopsies taken during it help confirm IBD and show whether it is Crohn’s disease or ulcerative colitis.
Treatment of Inflammatory Bowel Disease
Treatment aims to control inflammation, relieve symptoms, and keep patients in remission. The approach depends on the type of IBD, where it occurs, and how severe it is.
Anti-inflammatory medicines, such as 5-aminosalicylates and corticosteroids, are often used first.
Biologics were once reserved for severe cases, but they are now often a first-line option.
The available biologics include:
- Anti-TNF antibodies, such as infliximab and adalimumab
- Anti-integrin therapy, with vedolizumab
- IL-12/23 blockade, with ustekinumab
- Selective IL-23 inhibitors, such as risankizumab and mirikizumab
Surgery may be needed when medicines fail, or complications develop.
Applications of Inflammatory Bowel Disease Specimens for Research
Firstly, researchers value IBD Plasma Samples and Human Serum Samples because they allow them to look for proteins, metabolites, and inflammatory markers that change in IBD.
Secondly, Tissue samples help researchers study gene expression and immune cells in the gut wall.
Thirdly, Fresh-frozen tissue preserves DNA, RNA, and protein which makes it valuable for molecular studies. FFPE tissue preserves tissue structure, so researchers use it for histology and immunohistochemistry.
Similarly, matched PBMC samples help researchers study circulating immune cells and explore blood-based signatures of treatment response.
Moreover, Human Biofluid Samples are equally valuable. In a multi-omics study presented at ECCO 2025, researchers analyzed serum, urine, intestinal biopsies, and stool from 127 patients before and after treatment. They found differences in gene expression, proteins, metabolites, and gut microbes between responders and non-responders.
Similarly, researchers also use Human Stool Biospecimens to study the microbiome.
Furthermore, Crohn’s Disease Samples and Ulcerative Colitis Samples allow direct comparison of the two diseases.
It is also important to highlight that, as a researcher, you can also compare IBD with other Gastrointestinal Disease Samples and Inflammatory Disease Samples, such as rheumatoid arthritis. This is useful because different immune-related diseases share genetic susceptibility.
Finally, researchers can compare disease samples with normal healthy donor samples to separate true disease signals from normal variation.
Frequently Asked Questions
What are Inflammatory Bowel Disease Specimens used for?
Researchers use them to study gut inflammation, discover biomarkers, and predict treatment response. They also support drug discovery, diagnostics development, and translational research.
Do you provide matched biofluid samples with IBD tissue?
Yes. We offer matched human serum samples, human plasma samples, and peripheral blood mononuclear cells (PBMCs) from patients with IBD.
Are Bay Biosciences’ human biospecimens ethically sourced?
Yes. We collect all human samples through appropriate consent and IRB-approved protocols.
Supporting Your Research with Bay Biosciences
At Bay Biosciences, we provide human biospecimens to pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers.
Our comprehensive range of samples includes
- Inflammatory Bowel Disease Specimens
- Inflammatory Bowel Disease Samples
- Crohn’s Disease Samples
- Ulcerative Colitis Samples
- IBD Plasma Samples
- Ulcerative Colitis Serum and Plasma Samples
- Human Biofluid Samples
- Human serum samples
- Human plasma samples
- Peripheral blood mononuclear cells (PBMCs)
- Human blood samples
- FFPE tissue samples
- Fresh frozen tissue
- Normal healthy donor samples
If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us! Our team is always happy to help.